Lisa Boyette, MD, PhD, is a dedicated leader in clinical development, currently serving as the Executive Director of Clinical Design in Immunology at Eli Lilly and Company. They founded and led Curable Consulting from 2018 to 2021 and co-founded Curable, Inc., where they also held the role of CEO from 2014 to 2019. With experience as a Global Development Lead at Gilead Sciences and a consultant for Regeneron, they have significantly influenced the field of medicine. Lisa's academic contributions include serving as an Adjunct Assistant Professor at the University of Pittsburgh and a Mirzayan Science Policy Fellow at the Institute of Medicine. They are pursuing a Doctor of Philosophy, a Doctor of Medicine, and have also completed a postdoctoral fellowship at the University of Pittsburgh School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices